Br J Cancer. 2007 Jan 15;96(1):11-5.

Cancer risks among BRCA1 and BRCA2 mutation carriers.

Source

Institute of Medical Genetics, Shaare Zedek Medical Center, Hebrew University Medical School, Jerusalem, 91031, Israel. lahad@szmc.org.il

Abstract

BRCA1 and BRCA2 mutations increase breast and ovarian cancer risks substantially enough to warrant risk reduction surgery, despite variable risk estimates. Underlying this variability are methodological issues, and also complex genetic and nongenetic effects. Although many modifying factors are unidentified, known factors can already be incorporated in individualised risk prediction.

PMID:: 17213823; [PubMed - indexed for MEDLINE]
PMCID:: PMC2360226

Free PMC Article

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Labome Researcher Resource - ExactAntigen/Labome

Medical

Supplemental Content

Save items

Click here to read article using PubReader

Related citations in PubMed

Reproductive risk factors for ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study. [Lancet Oncol. 2007]
Reproductive risk factors for ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study.
McLaughlin JR, Risch HA, Lubinski J, Moller P, Ghadirian P, Lynch H, Karlan B, Fishman D, Rosen B, Neuhausen SL, et al. Lancet Oncol. 2007 Jan; 8(1):26-34.
Spectrum and characterisation of BRCA1 and BRCA2 deleterious mutations in high-risk Czech patients with breast and/or ovarian cancer. [BMC Cancer. 2008]
Spectrum and characterisation of BRCA1 and BRCA2 deleterious mutations in high-risk Czech patients with breast and/or ovarian cancer.
Machackova E, Foretova L, Lukesova M, Vasickova P, Navratilova M, Coene I, Pavlu H, Kosinova V, Kuklova J, Claes K. BMC Cancer. 2008 May 20; 8:140. Epub 2008 May 20.
Contribution of BRCA1 and BRCA2 mutations to inherited ovarian cancer. [Hum Mutat. 2007]
Contribution of BRCA1 and BRCA2 mutations to inherited ovarian cancer.
Ramus SJ, Harrington PA, Pye C, DiCioccio RA, Cox MJ, Garlinghouse-Jones K, Oakley-Girvan I, Jacobs IJ, Hardy RM, Whittemore AS, et al. Hum Mutat. 2007 Dec; 28(12):1207-15.
Review BRCA1 and BRCA2 mutations in breast and ovarian cancer syndrome: reflection on the Creighton University historical series of high risk families. [Fam Cancer. 2006]
Review BRCA1 and BRCA2 mutations in breast and ovarian cancer syndrome: reflection on the Creighton University historical series of high risk families.
Sinilnikova OM, Mazoyer S, Bonnardel C, Lynch HT, Narod SA, Lenoir GM. Fam Cancer. 2006; 5(1):15-20.
Review Management updates for women with a BRCA1 or BRCA2 mutation. [Mol Diagn Ther. 2007]
Review Management updates for women with a BRCA1 or BRCA2 mutation.
Nusbaum R, Isaacs C. Mol Diagn Ther. 2007; 11(3):133-44.

See reviews... See all...

Cited by 18 PubMed Central articles

Novel sequence variants and common recurrent polymorphisms of BRCA2 in Sri Lankan breast cancer patients and a family with BRCA1 mutations. [Exp Ther Med. 2011]
Novel sequence variants and common recurrent polymorphisms of BRCA2 in Sri Lankan breast cancer patients and a family with BRCA1 mutations.
DE Silva S, Tennekoon KH, Karunanayake EH, DE Silva W, Amarasinghe I, Angunawela P. Exp Ther Med. 2011 Nov; 2(6):1163-1170. Epub 2011 Aug 17.
Diagnosis of Fanconi Anemia: Mutation Analysis by Multiplex Ligation-Dependent Probe Amplification and PCR-Based Sanger Sequencing. [Anemia. 2012]
Diagnosis of Fanconi Anemia: Mutation Analysis by Multiplex Ligation-Dependent Probe Amplification and PCR-Based Sanger Sequencing.
Gille JJ, Floor K, Kerkhoven L, Ameziane N, Joenje H, de Winter JP. Anemia. 2012; 2012:603253. Epub 2012 Jun 21.
Age of 40 years or younger is an independent risk factor for locoregional failure in early breast cancer: a single-institutional analysis in saudi arabia. [J Oncol. 2012]
Age of 40 years or younger is an independent risk factor for locoregional failure in early breast cancer: a single-institutional analysis in saudi arabia.
Rudat V, El-Sweilmeen H, Fadel E, Brune-Erber I, Ahmad Nour A, Bushnag Z, Masri N, Altuwaijri S. J Oncol. 2012; 2012:370385. Epub 2012 Apr 1.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
References for this PMC Article
Citation referenced in PubMed article. Only valid for PubMed citations that are also in PMC.
Free in PMC
Free full text articles in PMC
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Cancer risks among BRCA1 and BRCA2 mutation carriers.
Cancer risks among BRCA1 and BRCA2 mutation carriers.
Br J Cancer. 2007 Jan 15 ;96(1):11-5.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: